Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1608
    -0.0075 (-0.64%)
     
  • GBP/USD

    1.2373
    -0.0066 (-0.53%)
     
  • Bitcoin GBP

    51,561.19
    +253.76 (+0.49%)
     
  • CMC Crypto 200

    1,334.09
    +21.47 (+1.58%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.34
    +0.61 (+0.74%)
     
  • GOLD FUTURES

    2,404.80
    +6.80 (+0.28%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Irish ingredients maker Kerry spends $735 mln on three U.S firms

DUBLIN, Oct (HKSE: 3366-OL.HK - news) 15 (Reuters) - Kerry has agreed to spend $735 million to buy three U.S (Other OTC: UBGXF - news) . firms to boost its flavouring, beverage and health product lines, adding around $300 million in annual revenue, the Irish company said on Thursday.

One of the largest suppliers of food ingredients with 24,000 employees in 120 countries, Kerry said it would buy Wisconsin-based Red Arrow Products, a supplier of smoke flavourings for meat as well as Island Oasis, which supplies beverages and equipment to the hospitality sector.

It (Other OTC: ITGL - news) will also buy Wellmune business from Biothera, which makes products targeted at boosting people's immune systems.

Kerry, said the three firms earned a combined $59 million in earnings before interest, taxation, depreciation and amortisation in financial 2014.

Kerry will finance the acquisitions from existing lines of credit. Its shares were up 1.5 percent at 1255 GMT, compared to an increase of 1.1 percent on the Irish market. (Reporting by Conor Humphries; editing by Jason Neely)